I believe the shares will have to be restricted under the current circumstances. As for the $8mm, it's a little lower than expected, but not altogether disappointing. Delex is a growth story, but my own estimates were a little high. I have to assume Covid affected their income as it did many other companies. The float is still very nice, and I'm sure the stock will move in the right direction
Q4 financials will definitely be audited, and the company is going places. We may see further amendments to the share structure moving forward as well.